List of Oncology Medication For

Uncategorized

LUMAKRAS (sotorasib) tablets

Brand Name: LUMAKRAS. Generic Name: (sotorasib). It is used to treat a type of lung cancer called non-small cell lung cancer (NSCLC).

Brand Name:	LUMAKRAS
Generic Name:	sotorasib
Strength:	• Tablets: 120 mg.
Manufacturer:	Amgen Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import LUMAKRAS (sotorasib) tablets” based on the information you provide.

LUMVOA (veligrotug-vvze) injection

Chronic Disease, Eye, Thyroid, Uncategorized

Brand: LUMVOA. API: veligrotug-vvze is used to treat Thyroid Eye Disease (TED).

Lumvoa (veligrotug-vvze) is a prescription biologic medication used to treat Thyroid Eye Disease (TED)

Brand Name:	LUMVOA – On Request
Generic Name:	veligrotug-vvze
Strength:	Injection: 500 mg/10 mL (50 mg/mL) solution in a single-dose vial
Manufacturer:	Viridian Therapeutics, Inc
Approved By:	EMA, USFDA
Get access to medicines:	In India
Price:	On Request

See full prescribing information for LUMVOA : Patient Information

Get access LUMVOA to treat Thyroid Eye Disease (TED) on a Named Patient Import Basis.

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to LUMVOA (veligrotug-vvze) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.

MYLOTARG (gemtuzumab ozogamicin) for Injection

Uncategorized

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import MYLOTARG (gemtuzumab ozogamicin) for Injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

ONUREG (azacitidine) Tablets

Uncategorized

ONUREG (azacitidine) tablets, for oral use. Initial U.S. Approval: 2004

ONUREG is a nucleoside metabolic inhibitor indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.
If you have any questions about your illness, talk to your doctor
Source Details: Patient Information

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ONUREG (azacitidine) Tablets” based on the information you provide.

POLIVY (polatuzumab vedotin-piiq) for Injection

Uncategorized

POLIVY (polatuzumab vedotin-piiq) for injection, for intravenous use. Initial U.S. Approval: 2019

POLIVY is a CD79b-directed antibody–drug conjugate indicated in combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified, after at least two prior therapies. POLIVY (polatuzumab vedotin-piiq) for injection is a preservative-free, white to grayish-white lyophilized powder, which has a cake-like appearance, supplied in a single-dose vial. Each carton (NDC 50242-105-01) contains one 140 mg single-dose vial. Generic Name: polatuzumab vedotin-piiq tablets Brand Name: POLIVY Dosage: For injection: 140 mg of polatuzumab vedotin-piiq as a lyophilized powder in a single-dose vial.
Source Details: Patient Information

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import POLIVY (polatuzumab vedotin-piiq) for Injection” based on the information you provide.

POTELIGEO (mogamulizumab-kpkc) injection

Uncategorized

Brand Name: POTELIGEO. Generic Name: (mogamulizumab-kpkc injection). It is used to treat rare skin cancers called cutaneous T-cell lymphoma (CTCL), specifically mycosis fungoides (MF) and Sézary syndrome (SS).

POTELIGEO is a CC chemokine receptor type 4 (CCR4)-directed monoclonal antibody indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy

Brand Name:	POTELIGEO
Generic Name:	mogamulizumab-kpkc injection
Strength:	• Injection: 20 mg/5 mL (4 mg/mL) solution in a single-dose vial
Manufacturer:	Kyowa Kirin, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “POTELIGEO (mogamulizumab-kpkc) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

PREVYMIS (letermovir) Injection

Uncategorized

PREVYMIS (letermovir) injection, for intravenous use Initial U.S. Approval: 2017

PREVYMIS is a CMV DNA terminase complex inhibitor indicated for prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import PREVYMIS (letermovir) Injection” based on the information you provide.

RETACRIT (epoetin alfa-epbx) Injection

Uncategorized

RETACRIT (epoetin alfa-epbx) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2018

RETACRIT is an erythropoiesis-stimulating agent (ESA) indicated for: • Treatment of anemia due to o Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis . o Zidovudine in patients with HIV-infection. o The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy . • Reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery.
If you have any questions about your illness, talk to your doctor
Source Details: Patient Information

Access Patient Name Basis Treatment

IPN, New Delhi can facilitate patient to import of “RETACRIT (epoetin alfa-epbx) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).

Saphnelo (anifrolumab)

Inflammatory, Uncategorized

Saphnelo (anifrolumab)

Saphnelo is used to treat a type of lupus called systemic lupus erythematosus (SLE). To be specific, the drug is for moderate to severe SLE in adults. Saphnelo should be prescribed in combination with other treatments for SLE, which may include: steroids, such as prednisone (Rayos)

Brand Name:	Saphnelo
Generic Name:	anifrolumab
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Saphnelo (anifrolumab)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Saphnelo (anifrolumab) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

SARCLISA (isatuximab-irfc) Injection

Uncategorized

SARCLISA (isatuximab-irfc) injection

SARCLISA is a CD38-directed cytolytic antibody indicated, in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor
If you have any questions about your illness, talk to your doctor
Source Details: Patient Information

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import SARCLISA (isatuximab-irfc) Injection ” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in